Edwards Lifesciences

-$1.34 (-1.22%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care.

CEO

Michael A. Mussallem

Employees

14,900

Headquarters

Irvine, California

Founded

1958

EW Key Statistics

Market cap

Price-Earnings ratio

46.91

Dividend yield

—

Average volume

2.91M

High today

$111.44

Low today

$107.15

Open price

$110.66

Volume

3.09M

52 Week high

$123.27

52 Week low

$78.44

EW News

Simply Wall StDec 1

Insider Buying: The Edwards Lifesciences Corporation Independent Director Just Bought 2.5% More Shares

Potential Edwards Lifesciences Corporation ( ) shareholders may wish to note that the Independent Director, Nicholas Valeriani, recently bought US$168k worth of

Simply Wall StNov 29

Edwards Lifesciences' earnings growth rate lags the 32% CAGR delivered to shareholders

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on a lighter note, a good company

Analyst ratings

Buy

54.2%

Hold

33.3%

Sell

12.5%

EW Earnings

$0.00

$0.21

$0.43

$0.64

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Jan 26, After Hours

Why Robinhood?

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. View more

Insider Buying: The Edwards Lifesciences Corporation Independent Director Just Bought 2.5% More Shares

Edwards Lifesciences' earnings growth rate lags the 32% CAGR delivered to shareholders

54%

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care.